IGMPI facebook News
IGMPI Logo
Institute of Good Manufacturing Practices India

(An Autonomous Body Recognized by Ministry of Commerce & Industry, Government of India)

Competency based placement focussed Education | Training | Research | Consultancy

ADMISSIONS NOTICE
18001031071 (Toll Free), +91 11 26512850
Regular | Part-time (Online Live Classes) Modes
Ginseng improves muscle recovery and lessens fatigue in athletes
Ginseng improves muscle recovery and lessens fatigue in athletes
The correlation between embracing unhealthful dietary habits and migraine severity
11 sick cases were reported in French cheese E. coli outbreak
More children added to the toll of those affected by excessive lead in applesauce
US FDA marketing authorization for miniaturized robotic-assisted surgery device: Virtual Incision
Digital app improves speech in stroke patients: NIHR study
Sanskritech introduces CDSCO-approved ultra-portable anytime health monitoring bag: Swandook
MGI Tech, Eurofins Genomics associate to advance precision health with revolutionary DNBSEQ-T20×2 sequencer and affiliated technologies
Fujifilm India embarked on Echelon Synergy at CT & MRI User Conclave
Non-compliance Report (EudraGMDP): Cross-Contamination Risk at Indian Pharmaceutical Company
Non-compliance Report (EudraGMDP): Cross-Contamination Risk at Indian Pharmaceutical Company
ViiV Healthcare demonstrates positive findings from the phase I study of cabotegravir long-acting injectable investigational formulation
ViiV Healthcare demonstrates positive findings from the phase I study of cabotegravir long-acting injectable investigational formulation
Novartis proposes positive data from the SMART study of Zolgensma in older and heavier children with SMA at the 2024 MDA conference
Novartis proposes positive data from the SMART study of Zolgensma in older and heavier children with SMA at the 2024 MDA conference
CASI and BioInvent declare positive data from lymphoma treatment trial
CASI and BioInvent declare positive data from lymphoma treatment trial
Ultimovacs declares trial results of UV1 cancer vaccine.
Pfizer notifies top-line results from Phase III RSV vaccine trial